Russia approves its single-dose Sputnik Light vaccine

Russia approved on Thursday a single-dose Sputnik Light Covid-19 vaccine, which is a version of  the world’s first registered vaccine against coronavirus - Sputnik V, the Russian Direct Investment Fund (RDIF) announced in a statement. 

The single dose of this vaccine demonstrated 79.4% efficacy according to analysed data taken from 28 days after the injection was administered as part of Russia’s mass vaccination programme between 5 December 2020 and 15 April 2021.

The statement also says that Sputnik Light has proven effective against all new strains of coronavirus, as demonstrated by the Gamaleya Center during laboratory tests. The vaccine is based on a well-studied human adenoviral vector platform that has proven to be safe and effective.

The cost of the Sputnik Light vaccine globally will be less than $10, while it has simple storage requirements, at +2 +8, which provide for easy logistics, the RDIF specified.

Similar articles